Biomedical literature mining using PubMed/MEDLINE for systematic review support
Scanned 9/2/2026
Install to Claude Code
npx -y skills add a5c-ai/babysitter --skill pubmed-literature-miner --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Pubmed Literature Miner?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/a5c-ai-pubmed-literature-miner-babysitter)More formats (shields.io, HTML) on the badges page.
---
name: pubmed-literature-miner
description: Biomedical literature mining using PubMed/MEDLINE for systematic review support
allowed-tools:
- Bash
- Read
- Write
- Edit
- Glob
- Grep
- WebFetch
metadata:
specialization: scientific-discovery
domain: science
category: literature-knowledge
phase: 6
graph:
domains: [domain:scientific-discovery]
specializations: [specialization:scientific-research-methods]
skillAreas: [skill-area:data-analysis, skill-area:statistical-analysis, skill-area:deep-web-research]
workflows: [workflow:experiment-design, workflow:peer-review-cycle]
roles: [role:research-engineer, role:computational-scientist]
---
# PubMed Literature Miner
## Purpose
Provides biomedical literature mining capabilities using PubMed/MEDLINE for systematic review support and PICO framework analysis.
## Capabilities
- MeSH term-based search
- PICO element extraction
- Abstract screening automation
- Citation deduplication
- PRISMA flow diagram data generation
- Full-text retrieval coordination
## Usage Guidelines
1. **MeSH Terms**: Use controlled vocabulary for precise searches
2. **PICO Framework**: Structure searches around population, intervention, comparison, outcome
3. **Screening**: Apply inclusion/exclusion criteria systematically
4. **PRISMA Compliance**: Generate required flow diagram data
## Tools/Libraries
- Biopython
- PyMed
- NCBI E-utilities
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!